Aims—To study the effect of omeprazole 20 mg twice daily on DGR and DGOR, using the technique of ambulatory bilirubin monitoring. Methods—Twenty three patients with Barrett’s oesophagus underwent ...

The aim of this trial was to compare short-term efficacy of an alginate (Gaviscon®, 4 × 10 mL/day) and omeprazole (20 mg/day) on GERD symptoms in general practice. Methods A 14-day multicentre ...

The GOOD trial was a 14-day multicentre randomised double-blind double-dummy non-inferiority trial comparing efficacy between Gaviscon® and omeprazole 20 mg. It recruited 90 general practitioners ...

According to the research, turmeric spice was found to help indigestion - the name for symptoms such as heartburn and bloating that can happen after eating.

Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...

Opaganib delivered a statistically significant increase in survival time when given at 150 mg/kg twice a day (BID ... the Company's Annual Report on Form 20-F filed with the SEC on April 8 ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

3,6 Similar results were reported from a phase 3, randomized, double-blind clinical trial of vonoprazan 20 mg vs lansoprazole 30 mg in Asian patients outside of Japan (ClinicalTrials.gov identifier: ...

Furthermore, in a carefully selected group of patients with symptoms refractory to PPI therapy, baclofen 20 mg three times a day significantly ... a study in healthy subjects treated with omeprazole ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.